PAVmed (PAVM) to Release Quarterly Earnings on Thursday

PAVmed (NASDAQ:PAVM) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 15th. Analysts expect PAVmed to post earnings of ($0.40) per share and revenue of $0.02 million for the quarter.

PAVmed Price Performance

PAVmed stock opened at $0.72 on Wednesday. The firm has a market capitalization of $12.36 million, a P/E ratio of -0.17 and a beta of 1.11. PAVmed has a 1-year low of $0.55 and a 1-year high of $2.35. The company’s 50-day moving average is $0.71 and its 200 day moving average is $0.77.

Wall Street Analyst Weigh In

Separately, Ascendiant Capital Markets increased their price target on PAVmed from $19.00 to $19.50 and gave the stock a “buy” rating in a report on Monday, April 21st.

About PAVmed

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.